Should Door to Unload Replace Door to Balloon and Other Protected PCI Applications?

To begin the course, please login or register by clicking ENROLL. After logging in, you will be able to complete the pretest and view the video/documents. You will have the option to complete the posttest, evaluation and receive credit. Some courses may have an associated cost.

Step Status
Video/Document(s)
Posttest
Evaluation
Starts On: 12/17/2019: 12:00 AM
Ends On: 6/30/2020: 12:00 AM
Session Type: Internet Activity Enduring Material
Credits: 0.5
Description:

Faculty

John M. Lasala, MD, PhD, FACC
Professor of Medicine, Director, Structural Heart Disease
Center for Valvular Heart Disease, Cardiovascular Division
Disclosures
Financial Relationships
- Research/Grant/Advisory Board: Ancora Healthcare Limited, Boston Scientific Corporation, Siemens,
- Consulting/Advisory Committees: AGA Medical/St Jude, Abbott Diagnostics Inc, Boston Scientific Corporation, Gore (W. L.) and Associates
- Speakers Bureau/Honoraria: AGA Medical/St Jude, AstratZeneca, Abiomed, Abbott Diagnostics Inc, Boston Scientific Corporation, Chiesi Farmaceutici S.p.A.
- Ownership Interest/Stock Equity: Abiomed

Financial Relationships: Speaker has nothing to disclose.

Presenters should indicate if speaking off label. This activity originated as a presentation at the CME activity, Contemporary Management of Cardiogenic Shock and Respiratory Failure, October 5, 2019, which was supported in part by BJC Hospital, Abiomed, Inc. and Medtronic.

Planning Committee

M. Faraz Masood, MD
Assistant Professor of Surgery, Department of Surgery, Division of Cardiothoracic Surgery
Financial Relationships: Speaker has nothing to disclose.

Janaka Dias, Business Director, Department of Surgery, Division of Cardiothoracic Surgery
Financial Relationships: Speaker has nothing to disclose.

Elizabeth Renner, Clinical Nurse Coordinator, Department of Surgery, Division of Cardiothoracic Surgery
Financial Relationships: Speaker has nothing to disclose.
Objectives: The intended result of this activity is increased knowledge/competence, and upon completion of this course, participants should be able to:
  • To determine appropriate temporary percutaneous mechanical device selection for patients in shock
Additional Information:
Target Audience: This course is designed for cardiologists, cardiovascular specialists, internists, critical care cardiac surgeons, nurse practitioners, nurses, physician assistants and all healthcare professionals who care for patients with cardiac function.

Publication Date: October 17, 2019
Expiration Date: June 30, 2020
Accreditation Information:
wustlcme
In support of improving patient care, Washington University School of Medicine in St. Louis is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Awarded for this Activity:
Credit Statement:
American Medical Association (AMA Credit)
Washington University School of Medicine in St. Louis designates this enduring material for a maximum of .5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
References:
  • O'Neil W et al, J Am Coll Cardiol Intv. 2016;9(9):871-883
  • Kahn JK, Almany SL in Practical Interventional Cardiology, 1997. Richenbacher WE, Pierce WS in Heart Disease, Ed Braunwald E, 5th Edition, Saunders 1997. Fuchs RM et al, Circulation 1983;68:117-23. Kern MJ et al, Circulation 1993;87:500-11. Kern MJ et al, JACC 1993;21:359-68
  • JACC 2015;66(23):2663
  • Meyns et al., J Am Coll Cardiol 2003; 41:1087-1095
Disclosure Information: It is the policy of Washington University School of Medicine in St. Louis, Continuing Medical Education, to ensure balance, independence, objectivity and scientific rigor in all its educational activities. All planners, faculty and other persons who may influence content of this CME activity have disclosed all relevant financial relationships with commercial interests. All disclosures have been reported and are indicated with their presentations. Any potential conflicts were addressed and resolved.

Presenters are also expected to openly disclose inclusion of discussion of any off-label, experimental, or investigational use of drugs or devices in their presentations.

Presentations are expected to be based on evidence that is accepted within the profession of medicine as adequate justification for their indication in the care of patients. All scientific research should conform to the generally accepted standards of experimental design, data collection and analysis. These presentations are not an endorsement of any commercial interests.

These presentations are the views and experiences of the presenters. The presenters' views do not represent the policy or position of Washington University School of Medicine in St. Louis. Washington University School of Medicine in St. Louis, Continuing Medical Education, is the provider for CME credits.


Powered By AI 4.5